Wealth Enhancement Advisory Services’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
AT
CISOA
DJSG
CIM
AC
MPWT
NAM
Wealth Enhancement Advisory Services's RMD Position: Q2 2026 in Review
Wealth Enhancement Advisory Services increased its ResMed (RMD) stake by 17% in Q2 2026, buying an estimated $1.69M and bringing the position to 56,083 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1417.
Wealth Enhancement Advisory Services first reported a position in RMD in Q1 2018 and has held it in 25 quarters since. The position peaked at $10.8M in Q3 2025. 147 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Wealth Enhancement Advisory Services held 56,083 shares of ResMed worth $2.52M as of Q2 2026.
- Wealth Enhancement Advisory Services bought 8,163 ResMed shares in Q2 2026, an estimated $1.69M.
- ResMed made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1417 holding.
- Wealth Enhancement Advisory Services first reported a position in ResMed in Q1 2018 and has held it in 25 quarters since.
- Wealth Enhancement Advisory Services's ResMed position peaked at $10.8M in Q3 2025.
- 147 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.